Cargando…
Late-phase miRNA-controlled oncolytic adenovirus for selective killing of cancer cells
Tissue-specific detargeting by miRNAs has been demonstrated to be a potent strategy to restrict adenoviral replication to cancer cells. These studies have generated adenoviruses with miRNA target sites placed in the 3′UTR of early gene products. In this work, we have studied the feasibility of provi...
Autores principales: | Bofill-De Ros, Xavier, Villanueva, Eneko, Fillat, Cristina |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4467430/ https://www.ncbi.nlm.nih.gov/pubmed/25714032 |
Ejemplares similares
-
Genome-wide miR-155 and miR-802 target gene identification in the hippocampus of Ts65Dn Down syndrome mouse model by miRNA sponges
por: Bofill-De Ros, Xavier, et al.
Publicado: (2015) -
Implications of MicroRNAs in Oncolytic Virotherapy
por: Bofill-De Ros, Xavier, et al.
Publicado: (2017) -
Inhibition of miR-222 by Oncolytic Adenovirus-Encoded miRNA Sponges Promotes Viral Oncolysis and Elicits Antitumor Effects in Pancreatic Cancer Models
por: Raimondi, Giulia, et al.
Publicado: (2021) -
Transgene codon usage drives viral fitness and therapeutic efficacy in oncolytic adenoviruses
por: Núñez-Manchón, Estela, et al.
Publicado: (2021) -
TENT2, TUT4, and TUT7 selectively regulate miRNA sequence and abundance
por: Yang, Acong, et al.
Publicado: (2022)